Association between hepatitis B virus infection and HLA-DR type in Korea

被引:112
作者
Ahn, SH
Han, KH
Park, JY
Lee, CK
Kang, SW
Chon, CY
Kim, YS
Park, K
Kim, DK
Moon, YM
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea
[3] Yonsei Univ, Coll Med, Dept Biostat, Seoul 120752, South Korea
关键词
D O I
10.1053/jhep.2000.7988
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although the mechanism of susceptibility to chronic persistent hepatitis B virus (HBV) infection is not well clarified, immunogenetic factors of the host may have a role. Recently a strong association between HLA-DR13 and the self-limited course of HBV infection has been reported. To determine whether the elimination of HBV is related to a particular HLA allele, we studied the HBV markers and HLA-DR Phenotypes of 1,272 Koreans who had visited Yonsei University Medical Center for renal transplantation. They included 330 renal transplant donors, Subjects were categorized into 3 different groups: the "Unexposed Group" (UE; n 946) with negative HBV markers, the "Chronic Carrier Group" (CC; n = 83), who were hepatitis B surface antigen (HBsAg)-positive, and the "Spontaneously Cleared Group" (SC; n = 243), who were HBsAg-negative with antibodies to HBsAg (anti-HBs) and hepatitis B core antigen (anti-HBc). HLA-DR4 was the most common type in all groups. HLA-DR6 was significantly more frequent in 69 of 243 subjects with SC (28.4%) than in 8 of 83 subjects with CC (9.6%) (P < .001; relative risk [RR] = 3.72). HLA-DR9 was significantly more frequent in CC than in SC (P < .001; RR = 0.33). HLA-DR13 showed a stronger association with the clearance of HBV than the other HLA-DRG subgroup. The distribution of HLA-DR phenotypes was similar regardless of renal disease. Our data indicate that HLA-DRG, especially HLA-DR13, is one of the host factors, which influences the immune response to HBV, and may be associated with self-elimination of HBV in Koreans.
引用
收藏
页码:1371 / 1373
页数:3
相关论文
共 17 条
[1]   HLA AND HEPATITIS-B INFECTION [J].
ALMARRI, A ;
BATCHELOR, JR .
LANCET, 1994, 344 (8931) :1194-1195
[2]   GENETIC PREDICTION OF NONRESPONSE TO HEPATITIS-B VACCINE [J].
ALPER, CA ;
KRUSKALL, MS ;
MARCUSBAGLEY, D ;
CRAVEN, DE ;
KATZ, AJ ;
BRINK, SJ ;
DIENSTAG, JL ;
AWDEH, Z ;
YUNIS, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (11) :708-712
[3]  
BEASLEY RP, 1981, LANCET, V2, P388
[4]  
CHISARI FV, 1978, VIRAL HEPATITIS, P245
[5]  
Diepolder HM, 1998, CLIN EXP IMMUNOL, V113, P244
[6]  
DUDLEY FJ, 1972, LANCET, V742, P1130
[7]  
HATTUM JV, 1987, HEPATOLOGY, V7, P11
[8]   HLA-DRB1*1301 and *1302 protect against chronic hepatitis B [J].
Hohler, T ;
Gerken, G ;
Notghi, A ;
Lubjuhn, R ;
Taheri, H ;
Protzer, U ;
Lohr, HF ;
Schneider, PM ;
zumBuschenfelde, KHM ;
Rittner, C .
JOURNAL OF HEPATOLOGY, 1997, 26 (03) :503-507
[9]   Fulminant hepatitis associated with hepatitis B virus e antigen negative infection: Importance of host factors [J].
Karayiannis, P ;
Alexopoulou, A ;
Hadziyannis, S ;
Thursz, M ;
Watts, R ;
Seito, S ;
Thomas, HC .
HEPATOLOGY, 1995, 22 (06) :1628-1634
[10]   THE ROLE OF HISTOCOMPATIBILITY ANTIGENS (HLA) IN INFECTION [J].
KASLOW, RA ;
SHAW, S .
EPIDEMIOLOGIC REVIEWS, 1981, 3 :90-114